Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 1;24(3):e319-e325.
doi: 10.4317/medoral.22370.

Persistent dysgeusia post-halitosis treatment: How does it impact the patients' quality of life?

Affiliations

Persistent dysgeusia post-halitosis treatment: How does it impact the patients' quality of life?

B-F-C Carvalho et al. Med Oral Patol Oral Cir Bucal. .

Abstract

Background: The objective of this study was to evaluate the quality of life and the presence of anxiety and depression in patients with dysgeusia post halitosis treatment.

Material and methods: Sixty patients were divided into three groups: Dysgeusia group (DG); Halitosis group (HG) and Control group (CG). The following instruments were used: Medical results study Short form health research of 36 items (SF-36), State-state anxiety inventory (STAI) and Self-report questionnaire-20 (SRQ-20).

Results: Of the 60 subjects studied, 85% were female and 15% were male. The evaluation of SF-36 indicated a statistically significant correlation between some domains for DG and showed low scores for Mental Health. In relation to HG, low scores were obtained for Bodily Pain, Vitality and Emotional Role. The CG showed low scores for Bodily Pain, General Health and Vitality. STAI was significant when DG was compared to HG and CG. The mean SRQ-20 score was higher in DG compared with the other groups.

Conclusions: Persistent dysgeusia post-halitosis treatment impacts on QoL generically in the Mental health domain, and specifically in trait and state anxiety. Symptoms of depression were also seen in this group of patients.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement:The authors have declared that no conflict of interest exist.

Figures

Figure 1
Figure 1
Characteristics of the samples (n=60). Dysgeusia group - DG, Halitosis group - HG, Control group - CG.
Figure 2
Figure 2
The experimental design. Dysgeusia group (DG), Halitosis group (HG), Control group (CG), Treatment plan (TP), Quality of life (QoL).

Similar articles

Cited by

References

    1. Markley EJ, Mattes-Kulig DA, Henkin RI. A classification of dysgeusia. J Am Diet Assoc. 1983;83:578–80. - PubMed
    1. Nagraj S K, George RP, Shetty N, Levenson D, Ferraiolo DM, Shrestha A. Interventions for managing taste disturbances. Cochrane Database Syst Rev. 2017;12:CD010470. - PMC - PubMed
    1. James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017;3:CD008676. - PMC - PubMed
    1. Litofsky NS, Resnick AG. The relationships between depression and brain tumors. J Neurooncol. 2009;94:153–61. - PubMed
    1. Heath TP, Melichar JK, Nutt DJ, Donaldson LF. Human taste thresholds are modulated by serotonin and noradrenaline. J Neurosci. 2006;26:12664–71. - PMC - PubMed